0.9% Sodium Chloride Injection, USP, 500 mL VIAFLEX Plastic Container
Product details
- 0.9% Sodium Chloride Injection, USP, 500 mL VIAFLEX Plastic Container
Company announcement
Baxter International Inc. is voluntarily recalling two lots of 0.9% Sodium Chloride Injection, USP, 500 mL VIAFLEX Plastic Container due to the potential presence of particulate matter identified as fiberglass.
The affected product was distributed from July 31, 2026, to August 3, 2026, to healthcare providers and distributors in Florida, Illinois, Indiana, Louisiana, Maryland, Missouri, North Carolina, New Jersey, Nevada, New York, Ohio, South Carolina, Texas, and Virginia.
No adverse events related to this issue have been reported as of August 25, 2026.
Risk:
Intravenous administration of 0.9% Sodium Chloride Injection containing fiberglass particulate matter may lead to serious adverse health consequences. Particulate matter can cause blockage and clotting in blood vessels, which can cut off blood flow to vital organs, lead to a life-threatening blood clot in the lungs (pulmonary embolism) and cause permanent organ damage or death. Additionally, these particles may cause local vein irritation, inflammatory reaction, aggravation of preexisting infections, and allergic reactions. As of August 25, 2026, Baxter has not received any reports of adverse events related to this issue.
Impacted states: Nationwide
Products:
- 0.9% Sodium Chloride Injection, USP, 500 mL VIAFLEX Plastic Container (UPC code(s): 0338004903)
Contact
For more information, call 888-229-0001.